Zhejiang Tianyu Pharmaceutical Co., Ltd.
SZSE:300702.SZ
20.8 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 426.153 | 476.981 | 476.753 | 1,296.236 | 142.096 | 346.308 | 220.027 | 179.956 | 145.211 | 96.451 | 109.958 |
| Short Term Investments
| -6.711 | -3.415 | 72.944 | 37.91 | -1.384 | -4.209 | 2.068 | 0.728 | -2.118 | -0.567 | 2.071 |
| Cash and Short Term Investments
| 426.153 | 476.981 | 549.698 | 1,334.146 | 142.096 | 346.308 | 222.095 | 180.684 | 145.211 | 96.451 | 112.029 |
| Net Receivables
| 607.469 | 490.268 | 536.219 | 507.5 | 401.808 | 394.846 | 247.86 | 238.349 | 224.108 | 189.464 | 158.192 |
| Inventory
| 1,889.681 | 2,017.183 | 1,598.502 | 994.844 | 871.966 | 602.799 | 461.067 | 358.914 | 324.103 | 247.855 | 229.504 |
| Other Current Assets
| 27.997 | 33.243 | 147.789 | 74.422 | 65.073 | 240.831 | 326.378 | 10.598 | 7.525 | 10.965 | 5.764 |
| Total Current Assets
| 2,951.299 | 3,017.675 | 2,832.208 | 2,910.912 | 1,480.943 | 1,584.784 | 1,257.4 | 788.544 | 700.948 | 544.735 | 505.489 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 2,792.969 | 2,810.01 | 2,464.993 | 1,663.474 | 1,177.257 | 866.125 | 677.193 | 597.98 | 531.773 | 473.307 | 403.107 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 445.657 | 423.943 | 374.753 | 241.345 | 165.711 | 149.648 | 153.242 | 113.037 | 77.436 | 48.328 | 49.484 |
| Goodwill and Intangible Assets
| 445.657 | 423.943 | 374.753 | 241.345 | 165.711 | 149.648 | 153.242 | 113.037 | 77.436 | 48.328 | 49.484 |
| Long Term Investments
| 96.564 | 90.985 | 5.661 | -27.849 | 11.884 | 14.846 | 8.569 | 9.409 | 12.255 | 10.704 | 8.066 |
| Tax Assets
| 8.254 | 15.864 | 15.003 | 9.05 | 3.172 | 6.836 | 4.658 | 2.738 | 2.68 | 2.113 | 3.03 |
| Other Non-Current Assets
| 43.38 | 57.273 | 107.984 | 92.636 | 1.26 | 7.081 | 5.59 | 3.321 | 1.26 | 5.7 | 2.611 |
| Total Non-Current Assets
| 3,386.824 | 3,398.075 | 2,968.394 | 1,978.656 | 1,359.285 | 1,044.536 | 849.252 | 726.484 | 625.404 | 540.151 | 466.298 |
| Total Assets
| 6,338.124 | 6,415.75 | 5,800.602 | 4,889.568 | 2,840.228 | 2,629.32 | 2,106.652 | 1,515.028 | 1,326.352 | 1,084.886 | 971.787 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 803.062 | 1,357.711 | 1,172.646 | 803.604 | 562.274 | 506.642 | 375.494 | 337.064 | 352.536 | 260.084 | 159.621 |
| Short Term Debt
| 1,582.584 | 1,122.145 | 516.288 | 216.374 | 53.845 | 484.169 | 337.901 | 486.521 | 409.83 | 321.65 | 334.552 |
| Tax Payables
| 42.406 | 16.29 | 15.042 | 56.408 | 5.897 | 19.834 | 4.62 | 1.89 | 8 | 4.919 | 1.546 |
| Deferred Revenue
| 176.3 | 189.551 | 187.537 | 209.236 | 94.184 | 105.358 | 80.771 | 46.201 | 53.54 | 32.691 | 21.456 |
| Other Current Liabilities
| 1.293 | 0.62 | 0.976 | 0.506 | 26.998 | 24.224 | 1.357 | 26.599 | 2.482 | 3.355 | 0.4 |
| Total Current Liabilities
| 2,563.239 | 2,670.028 | 1,877.447 | 1,229.72 | 737.301 | 1,120.393 | 795.523 | 896.385 | 818.389 | 617.78 | 516.03 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 216.139 | 165.067 | 120.971 | 48.059 | 14.85 | 23.727 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 64.415 | 69.19 | 70.919 | 50.83 | 43.276 | 30.201 | 23.469 | 11.334 | 12.192 | 10.889 | 1.769 |
| Deferred Tax Liabilities Non-Current
| 1.493 | 9.462 | 13.897 | 6.878 | 0.316 | 0 | 0 | 0 | 0 | 0 | 0.311 |
| Other Non-Current Liabilities
| 5.067 | 6.996 | 8.154 | 7.343 | 7.35 | 8.539 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 287.113 | 250.716 | 213.942 | 113.11 | 65.791 | 62.467 | 23.469 | 11.334 | 12.192 | 10.889 | 2.08 |
| Total Liabilities
| 2,850.352 | 2,920.744 | 2,091.388 | 1,342.83 | 803.092 | 1,182.86 | 818.992 | 907.719 | 830.58 | 628.669 | 518.11 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 347.977 | 347.977 | 347.977 | 182.224 | 182.224 | 182.017 | 120 | 90 | 90 | 90 | 90 |
| Retained Earnings
| 1,634.122 | 1,606.683 | 1,760.434 | 1,666.113 | 1,082.571 | 549.965 | 419.371 | 359.989 | 258.715 | 223.328 | 222.872 |
| Accumulated Other Comprehensive Income/Loss
| 108.084 | 142.758 | 145.215 | 103.33 | 90.738 | 47.682 | 53.665 | 42.566 | 32.301 | -0 | 0 |
| Other Total Stockholders Equity
| 1,397.587 | 1,397.587 | 1,455.588 | 1,595.072 | 681.603 | 666.795 | 694.624 | 114.755 | 114.755 | 142.889 | 140.806 |
| Total Shareholders Equity
| 3,487.771 | 3,495.006 | 3,709.213 | 3,546.738 | 2,037.136 | 1,446.46 | 1,287.66 | 607.309 | 495.772 | 456.217 | 453.677 |
| Total Equity
| 3,487.771 | 3,495.006 | 3,709.213 | 3,546.738 | 2,037.136 | 1,446.46 | 1,287.66 | 607.309 | 495.772 | 456.217 | 453.677 |
| Total Liabilities & Shareholders Equity
| 6,338.124 | 6,415.75 | 5,800.602 | 4,889.568 | 2,840.228 | 2,629.32 | 2,106.652 | 1,515.028 | 1,326.352 | 1,084.886 | 971.787 |